Duployez, N., Joudinaud, R., Boudry, A., Hunault, M., Fenwarth, L., Tavernier, E., Pautas, C., Bertoli, S., Tavitian, S., Raffoux, E., Hospital, M., Marchand, T., Heiblig, M., Chantepie, S., CarrĂ©, M., Peterlin, P., Gallego-Hernanz, M., Guieze, R., Simand, C., Turlure, P., Huynh, A., Lemasle, E., Gabellier, L., Lambert, J., Suarez, F., Chraibi, S., Sanhes, L., Celli-Lebras, K., Mineur, A., Gardin, C., Ifrah, N., Vey, N., Latour, R. P. D., Rigolot, L., Luquet, I., Penther, D., Itzykson, R., Delabesse, Ă., Hamel, J., Botton, S. D., Pigneux, A., Dombret, H., RĂ©cher, C., Preudhomme, C., Dumas, P. (2026). Prognostic impact of
                    <i>FLT3</i>
                    -ITD microclones in young adults with acute myeloid leukemia treated with intensive chemotherapy. Blood. https://doi.org/10.1182/blood.2025032829